March 2024 • PharmaTimes Magazine • 4-5

Contents

Features

Diversity in clinical trials – not just ‘nice to have’ but instrumental

Linking the climate-health nexus and collective responsibility

Boldly going to Medlab in search of the fabled tricorder

Navigating and embracing new life sciences marketing trends

Unleashing the potential of large language models across pharma

Analysis

Start the car – what lies ahead over the next ten years and beyond

Working out exosomes and optimising the delivery of treatments

Observational research for evidence in product withdrawal

Don’t downplay generative AI’s promise for drug discovery

The patent cliff, advanced modalities and an R&D IT reset

SmartPeople

14.
Passion project
Rippon Ubhi is the new Country Lead for Sanofi UK and Ireland

18.
Awaken the giant within
Why haven’t we been delivering more life sciences research in primary care?

23.
Blueprint for inclusion
Supporting women at work – a case study from Kyowa Kirin International

36.
Your moves
Where you're going and why you're going there